Lemaitre Vascular (LMAT) Share-based Compensation (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Share-based Compensation data on file, last reported at $2.1 million in Q1 2026.

• On a quarterly basis, Share-based Compensation rose 3506.9% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $7.9 million, a 56.94% increase from a year earlier, with the FY2025 full-year figure at $20.4 million, up 11.48% from the prior year.
• Share-based Compensation for Q1 2026 stood at $2.1 million, roughly flat from $2.1 million in the prior quarter.
• Over the last five years, Share-based Compensation for LMAT reached as high as $2.1 million in Q4 2025 and fell as low as $58000.0 in Q1 2025.
• Historically, Share-based Compensation has averaged $1.4 million across 5 years, with a median of $1.4 million in 2023.
• Across the five-year window, Share-based Compensation slumped 96.4% in 2025 and jumped 3506.9% in 2026, its largest moves.
• Year by year, Share-based Compensation stood at $684000.0 in 2022, then soared by 105.26% to $1.4 million in 2023, then climbed by 23.86% to $1.7 million in 2024, then climbed by 20.53% to $2.1 million in 2025, then slipped by 0.19% to $2.1 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $2.1 million in Q1 2026, $2.1 million in Q4 2025, and $1.7 million in Q3 2025.